Loading...
Astrana Health Q1 2025 Earnings Report
Astrana Health, Inc. reported its first quarter 2025 financial results, showing significant revenue growth and a decrease in net income compared to the prior year.
Key Takeaways
Astrana Health, Inc. reported a strong start to 2025 with total revenue increasing by 53% to $620.4 million. However, net income attributable to Astrana decreased to $6.7 million from $14.8 million in the prior year, and diluted EPS fell to $0.14 from $0.31. Adjusted EBITDA also saw a decrease to $36.4 million from $42.2 million.
Total revenue increased by 53% to $620.4 million in Q1 2025, up from $404.4 million in Q1 2024.
Care Partners revenue grew by 57% to $601.0 million, compared to $382.3 million in the same period last year.
Net income attributable to Astrana decreased to $6.7 million in Q1 2025 from $14.8 million in Q1 2024.
Diluted earnings per share (EPS) for Q1 2025 were $0.14, down from $0.31 in Q1 2024.
Revenue by Segment
Forward Guidance
Astrana Health is providing guidance for total revenue and Adjusted EBITDA for the quarter ending June 30, 2025, and reiterating guidance for the full year ending December 31, 2025, based on existing business conditions and assumptions. The full-year guidance includes approximately $15 million in expected costs for strategic investments in automation and AI, as well as integration costs for planned acquisitions, but excludes contributions from unclosed acquisitions.
Positive Outlook
- Projected total revenue for Q2 2025 is between $615 million and $655 million.
- Projected Adjusted EBITDA for Q2 2025 is between $45 million and $50 million.
- Full-year 2025 total revenue guidance is between $2.5 billion and $2.7 billion.
- Full-year 2025 Adjusted EBITDA guidance is between $170 million and $190 million.
- Continued strategic investments in automation and AI are expected to drive future growth.
Challenges Ahead
- Full-year 2025 guidance includes approximately $15 million in expected costs associated with strategic investments in automation and AI.
- Ongoing and expected integration costs associated with planned acquisitions are factored into the full-year guidance.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...